Publications
89 results
89 results
2024
Mata D, Lee J, Shanmugam V, Marcus C, Schrock A, Williams E, Ritterhouse L, Hickman R, Janovitz T, Patel N, et al. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results. Histopathology. 2024. doi:10.1111/his.15168
Mata D, Lee J, Shanmugam V, Marcus C, Schrock A, Williams E, Ritterhouse L, Hickman R, Janovitz T, Patel N, et al. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results. Histopathology. 2024. doi:10.1111/his.15168
Williams E, Vegas I, El-Senduny F, Zhang J, Mata D, Hiemenz M, Hughes S, Sa B, Kraft G, Gorbatov N, et al. Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma. Am J Surg Pathol. 2024. doi:10.1097/PAS.0000000000002191
Williams E, Vegas I, El-Senduny F, Zhang J, Mata D, Hiemenz M, Hughes S, Sa B, Kraft G, Gorbatov N, et al. Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma. Am J Surg Pathol. 2024. doi:10.1097/PAS.0000000000002191
Kerr D, Cloutier J, Margolis M, Mata D, Rodrigues Simoes N, Faquin W, Dias-Santagata D, Chopra S, Charville G, Wangsiricharoen S, et al. GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis. Mod Pathol. 2024;37(2):100386. doi:10.1016/j.modpat.2023.100386
Kerr D, Cloutier J, Margolis M, Mata D, Rodrigues Simoes N, Faquin W, Dias-Santagata D, Chopra S, Charville G, Wangsiricharoen S, et al. GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis. Mod Pathol. 2024;37(2):100386. doi:10.1016/j.modpat.2023.100386
2023
Williams E, Ravindranathan A, Gupta R, Stevers N, Suwala A, Hong C, Kim S, Yuan JB, Wu J, Barreto J, et al. Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol. 2023;25(12):2221–2236. doi:10.1093/neuonc/noad121
Williams E, Ravindranathan A, Gupta R, Stevers N, Suwala A, Hong C, Kim S, Yuan JB, Wu J, Barreto J, et al. Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol. 2023;25(12):2221–2236. doi:10.1093/neuonc/noad121
Galera P, Dilip D, Derkach A, Chan A, Zhang Y, Persuad S, Mishera T, Liu Y, Famulare C, Gao Q, et al. Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity. medRxiv. 2023. doi:10.1101/2023.11.01.23297696
Galera P, Dilip D, Derkach A, Chan A, Zhang Y, Persuad S, Mishera T, Liu Y, Famulare C, Gao Q, et al. Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity. medRxiv. 2023. doi:10.1101/2023.11.01.23297696
Torre M, Bukhari H, Nithianandam V, Zanella C, Mata D, Feany M. A Drosophila model relevant to chemotherapy-related cognitive impairment. Sci Rep. 2023;13(1):19290. doi:10.1038/s41598-023-46616-9
Torre M, Bukhari H, Nithianandam V, Zanella C, Mata D, Feany M. A Drosophila model relevant to chemotherapy-related cognitive impairment. Sci Rep. 2023;13(1):19290. doi:10.1038/s41598-023-46616-9
Yang S-R, Gedvilaite E, Ptashkin R, Chang J, Ziegler J, Mata D, Villafania L, Nafa K, Hechtman J, Benayed R, et al. Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation. J Thorac Oncol. 2023. doi:10.1016/j.jtho.2023.10.004
Yang S-R, Gedvilaite E, Ptashkin R, Chang J, Ziegler J, Mata D, Villafania L, Nafa K, Hechtman J, Benayed R, et al. Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation. J Thorac Oncol. 2023. doi:10.1016/j.jtho.2023.10.004
Crowley H, Georgantzoglou N, Tse J, Williams E, Mata D, Martin S, Guitart J, Bridge J, Linos K. Expanding Our Knowledge of Molecular Pathogenesis in Histiocytoses: Solitary Soft Tissue Histiocytomas in Children With a Novel CLTC::SYK Fusion. Am J Surg Pathol. 2023;47(10):1108–1115. doi:10.1097/PAS.0000000000002102
Crowley H, Georgantzoglou N, Tse J, Williams E, Mata D, Martin S, Guitart J, Bridge J, Linos K. Expanding Our Knowledge of Molecular Pathogenesis in Histiocytoses: Solitary Soft Tissue Histiocytomas in Children With a Novel CLTC::SYK Fusion. Am J Surg Pathol. 2023;47(10):1108–1115. doi:10.1097/PAS.0000000000002102
Torre M, Bukhari H, Nithianandam V, Zanella C, Mata D, Feany M. A model of chemotherapy-related cognitive impairment. bioRxiv. 2023. doi:10.1101/2023.06.01.543297
Torre M, Bukhari H, Nithianandam V, Zanella C, Mata D, Feany M. A model of chemotherapy-related cognitive impairment. bioRxiv. 2023. doi:10.1101/2023.06.01.543297
Grube V, Narla S, Mata D, Hafeez F. Comparing Follicular Extension Between Low-Grade and High-Grade Dysplastic Nevi. Am J Dermatopathol. 2023;45(6):423–424. doi:10.1097/DAD.0000000000002438
Grube V, Narla S, Mata D, Hafeez F. Comparing Follicular Extension Between Low-Grade and High-Grade Dysplastic Nevi. Am J Dermatopathol. 2023;45(6):423–424. doi:10.1097/DAD.0000000000002438
Velez Torres J, Mata D, Briski L, Green D, Cloutier J, Kerr D, Montgomery E, Rosenberg A. Sinonasal Myxoma: A Distinct Entity or a Myxoid Variant of Desmoid Fibromatosis? Mod Pathol. 2023:100189. doi:10.1016/j.modpat.2023.100189
Velez Torres J, Mata D, Briski L, Green D, Cloutier J, Kerr D, Montgomery E, Rosenberg A. Sinonasal Myxoma: A Distinct Entity or a Myxoid Variant of Desmoid Fibromatosis? Mod Pathol. 2023:100189. doi:10.1016/j.modpat.2023.100189
Hiemenz M, Kaur J, Kuang Z, Huang R, Harries L, Metzger D, Schiavone K, Millis S, Lin D, Lechpammer M, et al. POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2. Genes Chromosomes Cancer. 2023. doi:10.1002/gcc.23136
Hiemenz M, Kaur J, Kuang Z, Huang R, Harries L, Metzger D, Schiavone K, Millis S, Lin D, Lechpammer M, et al. POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2. Genes Chromosomes Cancer. 2023. doi:10.1002/gcc.23136